FDA grants Emergency Use Authorisation for Roche’s Coronavirus Test
Roche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read more
Respiratory
Ganovo and Ritonavir combo success in COVID-19 Clinical Trial
Ascletis Pharma’s investigational Ganovo and Ritonavir combo-therapy shows promise in COVID-19 Clinical Trial. Chinese biotech Ascletis Pharma Inc. (HKEX code:
Read more
Remdesivir shows promise in treatment against COVID-19
Preclinical data on remdesivir indicates that the drug may have potential as a treatment against the new coronavirus COVID-19. Remdesivir
Read more
China using Roche’s Actemra to treat COVID-19 patients
China has approved Actemra to treat COVID-19 patients. Actemra, Roshe’s anti-inflammatory drug, has received the green light in China as
Read more
Gilead starts Phase 3 trials to combat the novel coronavirus (COVID-19)
US biotech company Gilead Sciences has announced the start of two clinical Phase 3 trials to evaluate the safety and
Read more
Inovio to develop Novel Coronavirus Vaccine INO-4800
US-based pharmaceutical company Inovio is one of a number of pharmaceutical companies and research facilities urgently trying to develop a
Read more
Roche to acquire fibrotic diseases specialist Promedior for up to $1.39bn
Roche has entered into a definitive merger agreement to buy US-based fibrosis specialist Promedior for up to $1.39 billion. The
Read more
Cystic fibrosis drug Orkambi to be available free on the NHS
On October 24, 2019, NHS England reached a deal with the manufacturers Vertex Pharmaceuticals to make all three of their UK-licensed cystic
Read more